Summary

Eligibility
for people ages 18-80 (full criteria)
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Theodore Abraham (ucsf)
Headshot of Theodore Abraham
Theodore Abraham

Description

Summary

The EXCITE-HCM study is a randomized, controlled, blinded clinical trial designed to evaluate the effect of moderate intensity exercise training versus usual physicial activity on the improvement of HCM-related symptoms and cardiac function. About 70 participants will be recruited and randomized on a 1:1 ratio to either moderate intensity training or usual physicial activity interventions. Patients will be followed during a period of 24 weeks and assesesments as physical examination, questionnaires, 12 lead ecg's, biomarker levels, echocardiogram, Cardiac Magnetic resonance, PET and CPET will be performed to evaluate their response to the intervention.

Official Title

The EXerCise traIning To rEcovery in HCM Trial

Keywords

Hypertrophic Cardiomyopathy, Cardiomyopathies, Hypertrophy, Moderate Intensity Exercise Program

Eligibility

Location

  • University of California - San Francisco accepting new patients
    San Francisco California 94143 United States

Lead Scientist at University of California Health

  • Theodore Abraham (ucsf)
    My are echocardiography and hypertrophic cardiomyopathy (HCM). I direct the UCSF Echocardiography laboratory and co-direct the UCSF HCM Center of Excellence. I have expertise in transthoracic, stress and transesophageal echocardiography. I also have training and expertise in 3D and strain echocardiography.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT05818605
Study Type
Interventional
Participants
Expecting 70 study participants
Last Updated